Literature DB >> 17948934

Pouchitis.

En-Da Yu1, Zhuo Shao, Bo Shen.   

Abstract

While restorative proctocolectomy with ileal pouch-anal anastomosis has significantly improved the quality of life in patients with underlying ulcerative colitis who require surgery, complications can occur. Pouchitis as the most common long-term complication represents a spectrum of disease processes ranging from acute, antibiotic-responsive type to chronic antibiotic-refractory entity. Accurate diagnosis using a combined assessment of symptoms, endoscopy and histology and the stratification of clinical phenotypes is important for treatment and prognosis the disease. The majority of patients respond favorably to antibiotic therapy. However, management of chronic antibiotic-refractory pouchitis remains a challenge.

Entities:  

Mesh:

Year:  2007        PMID: 17948934      PMCID: PMC4172739          DOI: 10.3748/wjg.v13.i42.5598

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  79 in total

1.  Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial.

Authors:  P Gionchetti; F Rizzello; A Venturi; P Brigidi; D Matteuzzi; G Bazzocchi; G Poggioli; M Miglioli; M Campieri
Journal:  Gastroenterology       Date:  2000-08       Impact factor: 22.682

2.  Lymphocyte and macrophage subpopulations in pelvic ileal pouches.

Authors:  H J de Silva; M Jones; C Prince; M Kettlewell; N J Mortensen; D P Jewell
Journal:  Gut       Date:  1991-10       Impact factor: 23.059

3.  Antibiotic combination therapy in patients with chronic, treatment-resistant pouchitis.

Authors:  P Gionchetti; F Rizzello; A Venturi; F Ugolini; M Rossi; P Brigidi; R Johansson; A Ferrieri; G Poggioli; M Campieri
Journal:  Aliment Pharmacol Ther       Date:  1999-06       Impact factor: 8.171

4.  Endoscopic and histologic evaluation together with symptom assessment are required to diagnose pouchitis.

Authors:  B Shen; J P Achkar; B A Lashner; A H Ormsby; F H Remzi; C L Bevins; A Brzezinski; R E Petras; V W Fazio
Journal:  Gastroenterology       Date:  2001-08       Impact factor: 22.682

5.  Intestinal permeability in the ileal pouch.

Authors:  M N Merrett; N Soper; N Mortensen; D P Jewell
Journal:  Gut       Date:  1996-08       Impact factor: 23.059

6.  Budesonide enema in pouchitis--a double-blind, double-dummy, controlled trial.

Authors:  A Sambuelli; L Boerr; S Negreira; A Gil; G Camartino; S Huernos; Z Kogan; A Cabanne; A Graziano; H Peredo; I Doldán; O Gonzalez; E Sugai; M Lumi; J C Bai
Journal:  Aliment Pharmacol Ther       Date:  2002-01       Impact factor: 8.171

7.  Innate immune receptor genetic polymorphisms in pouchitis: is CARD15 a susceptibility factor?

Authors:  Carmen B Meier; Refaat A Hegazi; James Aisenberg; Peter E Legnani; Naris Nilubol; Gena M Cobrin; Richard H Duerr; Stephen R Gorfine; Joel J Bauer; David B Sachar; Scott E Plevy
Journal:  Inflamm Bowel Dis       Date:  2005-11       Impact factor: 5.325

8.  Prophylaxis of pouchitis onset with probiotic therapy: a double-blind, placebo-controlled trial.

Authors:  Paolo Gionchetti; Fernando Rizzello; Ulf Helwig; Alessandro Venturi; Karen Manon Lammers; Patrizia Brigidi; Beatrice Vitali; Gilberto Poggioli; Mario Miglioli; Massimo Campieri
Journal:  Gastroenterology       Date:  2003-05       Impact factor: 22.682

9.  Elevated platelet count before ileal pouch-anal anastomosis for ulcerative colitis is associated with the development of chronic pouchitis.

Authors:  Aderet Okon; Marla Dubinsky; Eric A Vasiliauskas; Konstantinos A Papadakis; Andrew Ippoliti; Stephan R Targan; Phillip R Fleshner
Journal:  Am Surg       Date:  2005-10       Impact factor: 0.688

10.  Cytokine production in pouchitis is similar to that in ulcerative colitis.

Authors:  R T Patel; I Bain; D Youngs; M R Keighley
Journal:  Dis Colon Rectum       Date:  1995-08       Impact factor: 4.585

View more
  7 in total

Review 1.  Top-down therapy for IBD: rationale and requisite evidence.

Authors:  Geert R D'Haens
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-02       Impact factor: 46.802

Review 2.  Surgical prophylaxis of pouchitis in ulcerative colitis.

Authors:  Giuseppe Brisinda; Serafino Vanella; Venanzio Valenza; Anna Crocco; Germano Perotti; Daniela Di Giuda; Giorgio Maria
Journal:  Dig Dis Sci       Date:  2010-12-03       Impact factor: 3.199

Review 3.  Probiotics in the gastrointestinal diseases of the elderly.

Authors:  G Malaguarnera; F Leggio; M Vacante; M Motta; M Giordano; A Bondi; F Basile; S Mastrojeni; A Mistretta; M Malaguarnera; M A Toscano; M Salmeri
Journal:  J Nutr Health Aging       Date:  2012-04       Impact factor: 4.075

4.  State-of-the-art of irritable bowel syndrome and inflammatory bowel disease research in 2008.

Authors:  Lynne V McFarland
Journal:  World J Gastroenterol       Date:  2008-05-07       Impact factor: 5.742

5.  The diameter of the ileal J-pouch-anal anastomosis as an important risk factor of pouchitis - clinical observations.

Authors:  Tomasz Banasiewicz; Ryszard Marciniak; Elżbieta Kaczmarek; Wiktor Meissner; Piotr Krokowicz; Jacek Paszkowski; Jarosław Walkowiak; Przemysław Majewski; Andrzej Marszałek; Michał Drews
Journal:  Med Sci Monit       Date:  2011-02

6.  The prognosis of clinical course and the analysis of the frequency of the inflammation and dysplasia in the intestinal J-pouch at the patients after restorative proctocolectomy due to FAP.

Authors:  Tomasz Banasiewicz; Ryszard Marciniak; Elzbieta Kaczmarek; Piotr Krokowicz; Jacek Paszkowski; Aleksandra Lozynska-Nelke; Piotr Gronek; Andrzej Plawski; Michal Drews
Journal:  Int J Colorectal Dis       Date:  2011-05-11       Impact factor: 2.571

7.  Characteristics of extremely early-onset pouchitis after proctocolectomy with ileal pouch-anal anastomosis.

Authors:  Yoshiki Okita; Toshimitsu Araki; Koji Tanaka; Tadanobu Shimura; Mikio Kawamura; Hiroyuki Fujikawa; Mikihiro Inoue; Yasuhiro Inoue; Keiichi Uchida; Yasuhiko Mohri; Masato Kusunoki
Journal:  J Gastrointest Surg       Date:  2012-12-20       Impact factor: 3.452

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.